Ignite Creation Date:
2025-12-25 @ 1:33 AM
Ignite Modification Date:
2026-05-27 @ 11:53 PM
Study NCT ID:
NCT00684294
Status:
TERMINATED
Last Update Posted:
2020-03-02
First Post:
2008-05-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I Trial of TGFB2-Antisense-GMCSF Gene Modified Autologous Tumor Cell (TAG) Vaccine for Advanced Cancer
Sponsor:
Mary Crowley Medical Research Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
MCMRC #08-08
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None